{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:20:42Z","timestamp":1791354042253,"version":"4.3.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA043421"],"award-info":[{"award-number":["K01DA043421"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA03777303"],"award-info":[{"award-number":["R01DA03777303"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA1104470"],"award-info":[{"award-number":["R01DA1104470"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DP2DA049295"],"award-info":[{"award-number":["DP2DA049295"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30AI036214"],"award-info":[{"award-number":["P30AI036214"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health Research Health Protection Research Unit in Evaluation of Interventions"},{"name":"Australian NHMRC senior principal research fellowship","award":["#1135991"],"award-info":[{"award-number":["#1135991"]}]},{"DOI":"10.13039\/501100003921","name":"Australian Government Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.drugalcdep.2020.108135","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T11:28:56Z","timestamp":1592998136000},"page":"108135","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis"],"prefix":"10.1016","volume":"213","author":[{"given":"Javier A.","family":"Cepeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vickerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geng","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Borquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha K.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.108135_bib0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/COH.0000000000000041","article-title":"Estimating the size of key populations: current status and future possibilities","volume":"9","author":"Abdul-Quader","year":"2014","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0010","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ije\/dyt243","article-title":"Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis","volume":"43","author":"Aspinall","year":"2014","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0015","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1473-3099(09)70021-0","article-title":"Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies","volume":"9","author":"Boily","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/add.14487","article-title":"The evolving drug epidemic of prescription opioid injection and its association with HCV transmission among people who inject drugs in Montr\u00e9al, Canada","volume":"114","author":"Bruneau","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.drugalcdep.2017.08.036","article-title":"Health outcomes associated with crack-cocaine use: systematic review and meta-analyses","volume":"180","author":"Butler","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0030","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1016\/S2352-3018(18)30168-1","article-title":"Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study","volume":"5","author":"Cepeda","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0035","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1600693","article-title":"Antiretroviral therapy for the prevention of HIV-1 transmission","volume":"375","author":"Cohen","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0140-6736(10)60753-2","article-title":"Amphetamine-group substances and HIV","volume":"376","author":"Colfax","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(19)32230-5","article-title":"Responding to global stimulant use: challenges and opportunities","author":"Farrell","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0050","first-page":"466","article-title":"HIV treatment as prevention among people who inject drugs\u2013a re-evaluation of the evidence","volume":"46","author":"Fraser","year":"2016","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0055","doi-asserted-by":"crossref","DOI":"10.1186\/s13011-015-0013-6","article-title":"Compulsory drug detention exposure is associated with not receiving antiretroviral treatment among people who inject drugs in Bangkok, Thailand: a cross-sectional study","volume":"10","author":"Hayashi","year":"2015","journal-title":"Substance abuse treatment, prevention, and policy"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0060","doi-asserted-by":"crossref","first-page":"509","DOI":"10.7326\/0003-4819-154-8-201104190-00001","article-title":"When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study","volume":"154","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0065","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1086\/590501","article-title":"HIV-1 transmission, by stage of infection","volume":"198","author":"Hollingsworth","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0070","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.drugalcdep.2018.07.038","article-title":"Over the influence: the HIV care continuum among methamphetamine-using men who have sex with men","volume":"192","author":"Jin","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1477-7517-11-30","article-title":"A cost-benefit\/cost-effectiveness analysis of an unsanctioned supervised smoking facility in the Downtown Eastside of Vancouver, Canada","volume":"11","author":"Jozaghi","year":"2014","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0080","first-page":"462","article-title":"The impact of needle and syringe programs on HIV and HCV transmissions in injecting drug users in Australia: a model-based analysis","volume":"51","author":"Kwon","year":"2009","journal-title":"JAIDS"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0085","doi-asserted-by":"crossref","first-page":"e5238","DOI":"10.1097\/MD.0000000000005238","article-title":"HIV incidence and behavioral correlates of HIV acquisition in a cohort of injection drug users in St Petersburg, Russia","volume":"95","author":"Kozlov","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0090","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1097\/QAD.0b013e3283578b5d","article-title":"Estimating the cost-effectiveness of needle-syringe programs in Australia","volume":"26","author":"Kwon","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0095","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1016\/S2214-109X(17)30373-X","article-title":"Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review","volume":"5","author":"Larney","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.04.002","article-title":"Transitioning from interferon-based to direct antiviral treatment options: A potential shift in barriers and facilitators of treatment initiation among people who use drugs?","author":"Makarenko","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0105","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/QAD.0000000000000613","article-title":"The impact of adherence to preexposure prophylaxis on the risk of HIV infection among people who inject drugs","volume":"29","author":"Martin","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0110","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2471\/BLT.12.108282","article-title":"Mortality among people who inject drugs: a systematic review and meta-analysis","volume":"91","author":"Mathers","year":"2013","journal-title":"B. World Health Organ."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/dar.12524","article-title":"Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico","volume":"37","author":"Meacham","year":"2018","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0120","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"Micallef","year":"2006","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0125","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jadohealth.2008.08.007","article-title":"Methamphetamine injection independently predicts hepatitis C infection among street-involved youth in a Canadian setting","volume":"44","author":"Miller","year":"2009","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1468-1293.2008.00557.x","article-title":"Loss to follow\u2010up in an international, multicentre observational study","volume":"9","author":"Mocroft","year":"2008","journal-title":"HIV Medicine"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0135","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/QAD.0000000000001458","article-title":"Impact of opioid substitution therapy on the HIV prevention benefit of antiretroviral therapy for people who inject drugs","volume":"31","author":"Mukandavire","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0140","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.drugalcdep.2018.07.007","article-title":"Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: effects on individual-level needle and syringe coverage","volume":"191","author":"O\u2019Keefe","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0145","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/hep.23959","article-title":"Treatment of acute hepatitis C in human immunodeficiency virus\u2013infected patients: The HEPAIG study","volume":"52","author":"Piroth","year":"2010","journal-title":"Hepatol."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0150","article-title":"Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs","author":"Platt","year":"2017","journal-title":"Cochrane Libr."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0155","first-page":"5","article-title":"Assessing the impact and cost-effectiveness of needle\/syringe provision and opiate substitution therapy on hepatitis C transmission among people who inject drugs in the United Kingdom: analysis of pooled datasets and economic modelling","author":"Platt","year":"2017","journal-title":"Public Health Res."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0160","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/add.14012","article-title":"Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane review and meta-analysis","volume":"113","author":"Platt","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.drugalcdep.2014.12.034","article-title":"Diverse HIV epidemics among people who inject drugs in Thailand: evidence from respondent-driven sampling surveys in Bangkok and Chiang Mai","volume":"148","author":"Prybylski","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1521\/aeap.2011.23.5.412","article-title":"Use of North America\u2019s first medically supervised safer injecting facility among HIV-positive injection drug users","volume":"23","author":"Reddon","year":"2011","journal-title":"AIDS Educ. Prev."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/10826084.2014.962661","article-title":"Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: a latent class analysis","volume":"50","author":"Roth","year":"2015","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0180","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants\u2014United States, 2015\u20132016","volume":"67","author":"Seth","year":"2018","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0185","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s10461-017-1836-0","article-title":"Polydrug use and heterogeneity in HIV risk among people who inject drugs in Estonia and Russia: a latent class analysis","volume":"22","author":"Tavitian-Exley","year":"2018","journal-title":"AIDS Behav."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0190","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/add.12846","article-title":"Influence of different drugs on HIV risk in people who inject: systematic review and meta\u2010analysis","volume":"110","author":"Tavitian\u2010Exley","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0195","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","article-title":"Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis","volume":"22","author":"Thein","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0200","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/gut.2010.217166","article-title":"Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men","volume":"60","author":"Thomson","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12954-016-0115-0","article-title":"A cross-sectional national survey assessing self-reported drug intake behavior, contact with the primary sector and drug treatment among service users of Danish drug consumption rooms","volume":"13","author":"Toth","year":"2016","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0210","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00002030-200304110-00014","article-title":"Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic","volume":"17","author":"Tyndall","year":"2003","journal-title":"AIDS."},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0215","series-title":"World Drug Report 2018","author":"United Nations Office on Drugs and Crime","year":"2018"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0220","series-title":"Global Synthetic Drugs Assessment: Amphetamine-type Stimulants and New Psychoactive Substances","author":"United Nations Office on Drugs Crime","year":"2017"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0225","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2013.01.020","article-title":"Is the HCV\u2013HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?","volume":"132","author":"Vickerman","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0230","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1360-0443.2012.03932.x","article-title":"Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings","volume":"107","author":"Vickerman","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0235","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.drugpo.2014.09.013","article-title":"Controlling HIV among people who inject drugs in Eastern Europe and Central Asia: insights from modelling","volume":"25","author":"Vickerman","year":"2014","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0240","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/add.14217","article-title":"Impact of current and scaled\u2010up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings\u2014what is required to achieve the WHO\u2019s HCV elimination targets?","volume":"113","author":"Ward","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108135_bib0245","series-title":"Guide to Starting and Managing Needle and Syringe Programmes","author":"World Health Organization","year":"2007"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620303008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620303008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:10:16Z","timestamp":1759828216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620303008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":49,"alternative-id":["S0376871620303008"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108135","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108135"}}